BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 21042941)

  • 1. Relationship between preoperative comorbidity, systemic inflammatory response, and survival in patients undergoing curative resection for colorectal cancer.
    Roxburgh CS; Platt JJ; Leitch EF; Kinsella J; Horgan PG; McMillan DC
    Ann Surg Oncol; 2011 Apr; 18(4):997-1005. PubMed ID: 21042941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum carcinoembryonic antigen monitoring after curative resection for colorectal cancer: clinical significance of the preoperative level.
    Park IJ; Choi GS; Lim KH; Kang BM; Jun SH
    Ann Surg Oncol; 2009 Nov; 16(11):3087-93. PubMed ID: 19629600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgery of colorectal cancer: surgical morbidity and five- and ten-year results in 2400 patients--monoinstitutional experience.
    Staib L; Link KH; Blatz A; Beger HG
    World J Surg; 2002 Jan; 26(1):59-66. PubMed ID: 11898035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic inflammatory response predicts survival following curative resection of colorectal cancer.
    McMillan DC; Canna K; McArdle CS
    Br J Surg; 2003 Feb; 90(2):215-9. PubMed ID: 12555298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver metastases from colorectal cancer: present surgical approach.
    Cavallari A; Vivarelli M; Bellusci R; Montalti R; De Ruvo N; Cucchetti A; De Vivo A; De Raffele E; Salone M; La Barba G
    Hepatogastroenterology; 2003; 50(54):2067-71. PubMed ID: 14696466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resection of localized recurrences after hepatectomy of colorectal cancer metastases.
    Fukunaga K; Takada Y; Otsuka M; Todoroki T; Fukao K
    Hepatogastroenterology; 2003; 50(54):1894-7. PubMed ID: 14696428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Change and current status of surgical treatment of colorectal cancer. Report of experiences of the Erlangen Surgical University Clinic].
    Gall FP; Hermanek P
    Chirurg; 1992 Apr; 63(4):227-34. PubMed ID: 1597084
    [No Abstract]   [Full Text] [Related]  

  • 8. [Is surgical therapy of locoregional recurrence of resected colorectal cancer effective?].
    Huber FT; Siewert JR
    Zentralbl Chir; 1993; 118(9):516-24. PubMed ID: 8237147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum carcinoembryonic antigen levels in patients operated for colorectal carcinoma.
    Veingerl B
    Wien Klin Wochenschr; 2001; 113 Suppl 3():32-8. PubMed ID: 15503618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the prognostic value of inflammation-based pathologic and biochemical criteria in patients undergoing potentially curative resection for colorectal cancer.
    Roxburgh CS; Salmond JM; Horgan PG; Oien KA; McMillan DC
    Ann Surg; 2009 May; 249(5):788-93. PubMed ID: 19387324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The value of follow-up after curative surgery of colorectal carcinoma.
    Safi F; Beyer HG
    Cancer Detect Prev; 1993; 17(3):417-24. PubMed ID: 8402729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Locoregional recurrence of colonic carcinoma: prognosis after surgical therapy].
    Fürst H; Arbogast H; Schildberg FW
    Langenbecks Arch Chir Suppl Kongressbd; 1997; 114():1093-5. PubMed ID: 9574343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival after repeat hepatic resection for recurrent colorectal metastases.
    Chiappa A; Zbar AP; Biella F; Staudacher C
    Hepatogastroenterology; 1999; 46(26):1065-70. PubMed ID: 10370668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative but not postoperative systemic inflammatory response correlates with survival in colorectal cancer.
    Crozier JE; McKee RF; McArdle CS; Angerson WJ; Anderson JH; Horgan PG; McMillan DC
    Br J Surg; 2007 Aug; 94(8):1028-32. PubMed ID: 17437250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of postoperative complications on long-term outcomes following curative resection for colorectal cancer.
    Law WL; Choi HK; Lee YM; Ho JW
    Ann Surg Oncol; 2007 Sep; 14(9):2559-66. PubMed ID: 17522945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum p53 antibody as tumor marker for follow-up of colorectal cancer after curative resection.
    Tang R; Yeh CY; Wang JY; Changchien CR; Chen JS; Hsieh LL
    Ann Surg Oncol; 2009 Sep; 16(9):2516-23. PubMed ID: 19565285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of follow-up colon examination among a population-based cohort of colorectal cancer patients.
    Rulyak SJ; Lieberman DA; Wagner EH; Mandelson MT
    Clin Gastroenterol Hepatol; 2007 Apr; 5(4):470-6; quiz 407. PubMed ID: 17270502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinicopathological characteristics and prognosis of patients with recurrent colorectal cancer].
    Song XM; Yang ZL; Wang L; Wang JP; Zhan WH; He YL; Huang YH; Lan P
    Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Nov; 9(6):492-4. PubMed ID: 17143792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic resection with reconstruction of the inferior vena cava or hepatic venous confluence for metastatic liver tumor from colorectal cancer.
    Aoki T; Sugawara Y; Imamura H; Seyama Y; Minagawa M; Hasegawa K; Kokudo N; Makuuchi M
    J Am Coll Surg; 2004 Mar; 198(3):366-72. PubMed ID: 14992737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controversies in laparoscopic surgery for colorectal cancer.
    Sawyer MA; Sawyer EM
    Curr Surg; 2004; 61(4):334-41. PubMed ID: 15276336
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.